학술논문

Germline NPAT inactivating variants as cause of hereditary colorectal cancer
Document Type
Article
Source
European Journal of Human Genetics: EJHG; July 2024, Vol. 32 Issue: 7 p871-875, 5p
Subject
Language
ISSN
10184813; 14765438
Abstract
Two independent exome sequencing initiatives aimed to identify new genes involved in the predisposition to nonpolyposis colorectal cancer led to the identification of heterozygous loss-of-function variants in NPAT, a gene that encodes a cyclin E/CDK2 effector required for S phase entry and a coactivator of histone transcription, in two families with multiple members affected with colorectal cancer. Enrichment of loss-of-function and predicted deleterious NPATvariants was identified in familial/early-onset colorectal cancer patients compared to non-cancer gnomAD individuals, further supporting the association with the disease. Previous studies in Drosophila models showed that NPATabrogation results in chromosomal instability, increase of double strand breaks, and induction of tumour formation. In line with these results, colorectal cancers with NPATsomatic variants and no DNA repair defects have significantly higher aneuploidy levels than NPAT-wildtype colorectal cancers. In conclusion, our findings suggest that constitutional inactivating NPATvariants predispose to mismatch repair-proficient nonpolyposis colorectal cancer.